SUMMIT THERAPEUTICS INC (SMMT) Stock Earnings & Estimates
USA - NASDAQ:SMMT - US86627T1088 - Common Stock
20.035 USD
-0.95 (-4.55%)
20.0394 USD
+0 (+0.02%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 860K -98.49% | 1.81M 110.47% | 710K -60.77% | N/A -100.00% | 17.251M | 105.44M 511.21% | 858.97M 714.65% | 2.458B 186.16% | 4.562B 85.60% | 6.901B 51.27% | 8.865B 28.46% | |||
| EBITDA YoY % growth | -50.78M -488.82% | -84.84M -67.07% | -62.36M 26.50% | N/A -41.98% | -224.001M -138.21% | -284.09M -34.70% | -510.403M -79.66% | -611.044M -19.72% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -52.33M -563.51% | -86.19M -64.70% | -63.62M 26.19% | N/A -39.48% | -226.217M -137.78% | -947.537M -349.09% | -681.187M 28.11% | -799.29M -17.34% | -247.093M 69.09% | 1.227B 596.57% | 3.1B 152.65% | 5.112B 64.90% | 6.763B 32.30% | |
| Operating Margin | -6,084.88% | -4,761.88% | -8,960.56% | N/A | N/A | N/A | -3,948.68% | -758.05% | -28.77% | 49.92% | 67.95% | 74.08% | 76.29% | |
| EPS YoY % growth | -3.39 | N/A | N/A | N/A | -0.31 -106.67% | -1.07 -245.48% | -0.60 43.71% | -0.65 -7.36% | -0.25 61.19% | 1.16 560.01% | 3.06 164.85% | 4.89 59.89% | 6.54 33.58% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -80.48% | -0.13 -47.33% | -0.14 -14.75% | -0.29 7.71% | -0.29 -103.11% | -0.83 -529.23% | -0.87 -534.07% | -0.89 -209.45% | -0.91 -209.22% |
| Revenue Q2Q % growth | 84.997K | 484.5K | 3.851M | N/A | N/A | N/A | N/A | ||
| EBITDA Q2Q % growth | -113.563M -73.31% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -151.181M -130.41% | -208.121M -182.00% | -219.673M -196.71% | -257.679M -304.08% | -266.719M -76.42% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.31 -287.50% | -0.13 | -0.18 | -130.56% |
| Q2 2025 Q2Q % growth | -0.12 -33.33% | -0.10 | -0.02 | -24.49% |
| Q1 2025 Q2Q % growth | -0.09 -50.00% | -0.09 | 0.00 | 3.04% |
| Q4 2024 Q2Q % growth | -0.08 -100.00% | -0.08 | 0.00 | 3.77% |
| Q3 2024 Q2Q % growth | -0.08 -166.67% | -0.07 | -0.01 | -17.64% |
| Q2 2024 Q2Q % growth | -0.09 -350.00% | -0.06 | -0.03 | -42.31% |
| Q1 2024 Q2Q % growth | -0.06 | -0.06 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.04 42.86% | % | ||
| Q3 2023 Q2Q % growth | -0.03 78.57% | % | ||
| Q3 2022 Q2Q % growth | -0.14 86.00% | % | ||
| Q3 2021 Q2Q % growth | -1.00 19.35% | -0.30 | -0.70 | -238.07% |
| Q2 2021 Q2Q % growth | 99.77% | 0.00 | % | |
| Q1 2021 Q2Q % growth | -1.05 -950.00% | 0.00 | -1.05 | -39,799.68% |
| Q4 2020 Q2Q % growth | -0.90 | 0.00 | -0.90 | -40,006.95% |
| Q3 2020 Q2Q % growth | -1.24 | -0.01 | -1.23 | -10,852.13% |
| Q2 2020 Q2Q % growth | -1.15 | -0.02 | -1.13 | -5,537.25% |
| Q1 2020 Q2Q % growth | -0.10 | -0.02 | -0.08 | -390.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2024 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | 270K 22.73% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | 220K -83.21% | % | ||
| Q2 2022 Q2Q % growth | 240K 300.00% | % | ||
| Q1 2022 Q2Q % growth | 250K 31.58% | % | ||
| Q4 2021 Q2Q % growth | 250K 31.58% | % | ||
| Q3 2021 Q2Q % growth | 1.31M 627.78% | 1.31M | % | |
| Q2 2021 Q2Q % growth | 60K -64.71% | 4.518M | -4.458M | -98.67% |
| Q1 2021 Q2Q % growth | 190K -40.63% | 4.495M | -4.305M | -95.77% |
| Q4 2020 Q2Q % growth | 190K | 3.913M | -3.723M | -95.14% |
| Q3 2020 Q2Q % growth | 180K 20.00% | 4.041M | -3.861M | -95.55% |
| Q2 2020 Q2Q % growth | 170K 6.25% | 4.59M | -4.42M | -96.30% |
| Q1 2020 Q2Q % growth | 320K -34.69% | 5.171M | -4.851M | -93.81% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -19.55% | -162.83% |
| Revenue | N/A | N/A | N/A | N/A |